APO Research

APO RESEARCH · REPORT

Protein Crystallization and Crystallography

The Global Protein Crystallization and Crystallography Industry 2016 Market Research Report is a professional and in-depth study on the current state of the protein crystallization and crystallography industry.

Product & engineering

Understand the product.

The Global Protein Crystallization and Crystallography Industry 2016 Market Research Report is a professional and in-depth study on the current state of the protein crystallization and crystallography industry.

Selected research

Market Outlook & Growth Opportunities

Global Protein Crystallization and Crystallography Market Outlook and Growth Opportunities 2026

Market perspective

The Global Protein Crystallization and Crystallography Industry 2016 Market Research Report is a professional and in-depth study on the current state of the protein crystallization and crystallography industry.

Europe is the largest Protein Crystallization and Crystallography market with about 48% market share. North America is follower, accounting for about 42% market share.

The key players are Rigaku, Jena Bioscience, Bruker, Formulatrix, Art Robbins Instruments, Molecular Dimensions, Tecan, FEI, MiTeGen, QIAGEN etc. Top 3 companies occupied about 58% market share.

Read the full market overview

This report provides an overview of the global Protein Crystallization and Crystallography market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Protein Crystallization and Crystallography and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Protein Crystallization and Crystallography revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Protein Crystallization and Crystallography market.

Protein Crystallization and Crystallography Segment by Company

Rigaku

Jena Bioscience

Bruker

Formulatrix

Art Robbins Instruments

Molecular Dimensions

Tecan

FEI

MiTeGen

QIAGEN

Protein Crystallization and Crystallography Segment by Type

Reagents/Consumables

Instruments

Protein Crystallization and Crystallography Segment by Application

Pharmaceutical

Biotechnology companies

Academic institutions

Others

Protein Crystallization and Crystallography Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Protein Crystallization and Crystallography status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Protein Crystallization and Crystallography key companies, revenue, market share, and recent developments.

3. To split the Protein Crystallization and Crystallography breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Protein Crystallization and Crystallography market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Protein Crystallization and Crystallography significant trends, drivers, influence factors in global and regions.

6. To analyze Protein Crystallization and Crystallography competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein Crystallization and Crystallography market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Protein Crystallization and Crystallography and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein Crystallization and Crystallography.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Protein Crystallization and Crystallography industry.

Chapter 3: Detailed analysis of Protein Crystallization and Crystallography company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Protein Crystallization and Crystallography in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Protein Crystallization and Crystallography in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Protein Crystallization and Crystallography Industry Trends Table 2. Protein Crystallization and Crystallography Industry Drivers Table 3. Protein Crystallization and Crystallography Industry Opportunities and Challenges Table 4. Protein Crystallization and Crystallography Industry Restraints Table 5. Global Protein Crystallization and Crystallography Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Protein Crystallization and Crystallography Revenue Share by Company (2021-2026) Table 7. Global Protein Crystallization and Crystallography Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Protein Crystallization and Crystallography Key Company Manufacturing Base & Headquarters Table 9. Global Protein Crystallization and Crystallography Company, Product Type & Application Table 10. Global Protein Crystallization and Crystallography Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Protein Crystallization and Crystallography by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Reagents/Consumables Table 15. Significant Companies of Instruments Table 16. Global Protein Crystallization and Crystallography Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Protein Crystallization and Crystallography Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Protein Crystallization and Crystallography Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Protein Crystallization and Crystallography Sales Value Share by Type (2021-2026) Table 20. Global Protein Crystallization and Crystallography Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Biotechnology companies Table 23. Significant Companies of Academic institutions Table 24. Significant Companies of Others Table 25. Global Protein Crystallization and Crystallography Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Protein Crystallization and Crystallography Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Protein Crystallization and Crystallography Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Protein Crystallization and Crystallography Sales Value Share by Application (2021-2026) Table 29. Global Protein Crystallization and Crystallography Sales Value Share by Application (2027-2032) Table 30. Global Protein Crystallization and Crystallography Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Protein Crystallization and Crystallography Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Protein Crystallization and Crystallography Sales Value Share by Region (2021-2026) Table 33. Global Protein Crystallization and Crystallography Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Protein Crystallization and Crystallography Sales Value Share by Region (2027-2032) Table 35. Global Protein Crystallization and Crystallography Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Protein Crystallization and Crystallography Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Protein Crystallization and Crystallography Sales Value Market Share by Country (2021-2026) Table 38. Global Protein Crystallization and Crystallography Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Protein Crystallization and Crystallography Sales Value Market Share by Country (2027-2032) Table 40. Rigaku Company Information Table 41. Rigaku Business Overview Table 42. Rigaku Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Rigaku Protein Crystallization and Crystallography Product Portfolio Table 44. Rigaku Recent Development Table 45. Jena Bioscience Company Information Table 46. Jena Bioscience Business Overview Table 47. Jena Bioscience Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Jena Bioscience Protein Crystallization and Crystallography Product Portfolio Table 49. Jena Bioscience Recent Development Table 50. Bruker Company Information Table 51. Bruker Business Overview Table 52. Bruker Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Bruker Protein Crystallization and Crystallography Product Portfolio Table 54. Bruker Recent Development Table 55. Formulatrix Company Information Table 56. Formulatrix Business Overview Table 57. Formulatrix Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Formulatrix Protein Crystallization and Crystallography Product Portfolio Table 59. Formulatrix Recent Development Table 60. Art Robbins Instruments Company Information Table 61. Art Robbins Instruments Business Overview Table 62. Art Robbins Instruments Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Art Robbins Instruments Protein Crystallization and Crystallography Product Portfolio Table 64. Art Robbins Instruments Recent Development Table 65. Molecular Dimensions Company Information Table 66. Molecular Dimensions Business Overview Table 67. Molecular Dimensions Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Molecular Dimensions Protein Crystallization and Crystallography Product Portfolio Table 69. Molecular Dimensions Recent Development Table 70. Tecan Company Information Table 71. Tecan Business Overview Table 72. Tecan Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Tecan Protein Crystallization and Crystallography Product Portfolio Table 74. Tecan Recent Development Table 75. FEI Company Information Table 76. FEI Business Overview Table 77. FEI Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. FEI Protein Crystallization and Crystallography Product Portfolio Table 79. FEI Recent Development Table 80. MiTeGen Company Information Table 81. MiTeGen Business Overview Table 82. MiTeGen Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. MiTeGen Protein Crystallization and Crystallography Product Portfolio Table 84. MiTeGen Recent Development Table 85. QIAGEN Company Information Table 86. QIAGEN Business Overview Table 87. QIAGEN Protein Crystallization and Crystallography Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. QIAGEN Protein Crystallization and Crystallography Product Portfolio Table 89. QIAGEN Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Protein Crystallization and Crystallography Product Image Figure 2. Global Protein Crystallization and Crystallography Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Protein Crystallization and Crystallography Market Size (2021-2032) & (US$ Million) Figure 4. Global Protein Crystallization and Crystallography Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Reagents/Consumables Image Figure 8. Instruments Image Figure 9. Global Protein Crystallization and Crystallography Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Protein Crystallization and Crystallography Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Protein Crystallization and Crystallography Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Biotechnology companies Image Figure 14. Academic institutions Image Figure 15. Others Image Figure 16. Global Protein Crystallization and Crystallography Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Protein Crystallization and Crystallography Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Protein Crystallization and Crystallography Sales Value Share by Application (2021-2032) Figure 19. Global Protein Crystallization and Crystallography Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Protein Crystallization and Crystallography Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Protein Crystallization and Crystallography Sales Value (2021-2032) & (US$ Million) Figure 22. North America Protein Crystallization and Crystallography Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Protein Crystallization and Crystallography Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Protein Crystallization and Crystallography Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Protein Crystallization and Crystallography Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Protein Crystallization and Crystallography Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Protein Crystallization and Crystallography Sales Value (2021-2032) & (US$ Million) Figure 28. South America Protein Crystallization and Crystallography Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Protein Crystallization and Crystallography Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Protein Crystallization and Crystallography Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents/Consumables
  • Instruments
Applications
  • Pharmaceutical
  • Biotechnology companies
  • Academic institutions
  • Others
Companies covered
  • Rigaku
  • Jena Bioscience
  • Bruker
  • Formulatrix
  • Art Robbins Instruments
  • Molecular Dimensions
  • Tecan
  • FEI
  • MiTeGen
  • QIAGEN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Protein Crystallization and Crystallography Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Protein Crystallization and Crystallography Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Protein Crystallization and Crystallography Market Dynamics
  1. 2.1 Protein Crystallization and Crystallography Industry Trends
  2. 2.2 Protein Crystallization and Crystallography Industry Drivers
  3. 2.3 Protein Crystallization and Crystallography Industry Opportunities and Challenges
  4. 2.4 Protein Crystallization and Crystallography Industry Restraints
3 Protein Crystallization and Crystallography Market by Company
  1. 3.1 Global Protein Crystallization and Crystallography Company Revenue Ranking in 2025
  2. 3.2 Global Protein Crystallization and Crystallography Revenue by Company (2021-2026)
  3. 3.3 Global Protein Crystallization and Crystallography Company Ranking (2024-2026)
  4. 3.4 Global Protein Crystallization and Crystallography Company Manufacturing Base and Headquarters
  5. 3.5 Global Protein Crystallization and Crystallography Company Product Type and Application
  6. 3.6 Global Protein Crystallization and Crystallography Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Protein Crystallization and Crystallography Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Protein Crystallization and Crystallography Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Protein Crystallization and Crystallography Market by Type
  1. 4.1 Protein Crystallization and Crystallography Type Introduction
  2. 4.1.1 Reagents/Consumables
  3. 4.1.2 Instruments
  4. 4.2 Global Protein Crystallization and Crystallography Sales Value by Type
  5. 4.2.1 Global Protein Crystallization and Crystallography Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Protein Crystallization and Crystallography Sales Value by Type (2021-2032)
  7. 4.2.3 Global Protein Crystallization and Crystallography Sales Value Share by Type (2021-2032)
5 Protein Crystallization and Crystallography Market by Application
  1. 5.1 Protein Crystallization and Crystallography Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Biotechnology companies
  4. 5.1.3 Academic institutions
  5. 5.1.4 Others
  6. 5.2 Global Protein Crystallization and Crystallography Sales Value by Application
  7. 5.2.1 Global Protein Crystallization and Crystallography Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Protein Crystallization and Crystallography Sales Value by Application (2021-2032)
  9. 5.2.3 Global Protein Crystallization and Crystallography Sales Value Share by Application (2021-2032)
6 Protein Crystallization and Crystallography Regional Value Analysis
  1. 6.1 Global Protein Crystallization and Crystallography Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Protein Crystallization and Crystallography Sales Value by Region (2021-2032)
  3. 6.2.1 Global Protein Crystallization and Crystallography Sales Value by Region: 2021-2026
  4. 6.2.2 Global Protein Crystallization and Crystallography Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Protein Crystallization and Crystallography Sales Value (2021-2032)
  7. 6.3.2 North America Protein Crystallization and Crystallography Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Protein Crystallization and Crystallography Sales Value (2021-2032)
  10. 6.4.2 Europe Protein Crystallization and Crystallography Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Protein Crystallization and Crystallography Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Protein Crystallization and Crystallography Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Protein Crystallization and Crystallography Sales Value (2021-2032)
  16. 6.6.2 South America Protein Crystallization and Crystallography Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Protein Crystallization and Crystallography Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Protein Crystallization and Crystallography Sales Value Share by Country, 2025 VS 2032
7 Protein Crystallization and Crystallography Country-level Value Analysis
  1. 7.1 Global Protein Crystallization and Crystallography Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Protein Crystallization and Crystallography Sales Value by Country (2021-2032)
  3. 7.2.1 Global Protein Crystallization and Crystallography Sales Value by Country (2021-2026)
  4. 7.2.2 Global Protein Crystallization and Crystallography Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Protein Crystallization and Crystallography Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Protein Crystallization and Crystallography Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Protein Crystallization and Crystallography Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Rigaku
  2. 8.1.1 Rigaku Company Information
  3. 8.1.2 Rigaku Business Overview
  4. 8.1.3 Rigaku Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Rigaku Protein Crystallization and Crystallography Product Portfolio
  6. 8.1.5 Rigaku Recent Developments
  7. 8.2 Jena Bioscience
  8. 8.2.1 Jena Bioscience Company Information
  9. 8.2.2 Jena Bioscience Business Overview
  10. 8.2.3 Jena Bioscience Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jena Bioscience Protein Crystallization and Crystallography Product Portfolio
  12. 8.2.5 Jena Bioscience Recent Developments
  13. 8.3 Bruker
  14. 8.3.1 Bruker Company Information
  15. 8.3.2 Bruker Business Overview
  16. 8.3.3 Bruker Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bruker Protein Crystallization and Crystallography Product Portfolio
  18. 8.3.5 Bruker Recent Developments
  19. 8.4 Formulatrix
  20. 8.4.1 Formulatrix Company Information
  21. 8.4.2 Formulatrix Business Overview
  22. 8.4.3 Formulatrix Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Formulatrix Protein Crystallization and Crystallography Product Portfolio
  24. 8.4.5 Formulatrix Recent Developments
  25. 8.5 Art Robbins Instruments
  26. 8.5.1 Art Robbins Instruments Company Information
  27. 8.5.2 Art Robbins Instruments Business Overview
  28. 8.5.3 Art Robbins Instruments Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Art Robbins Instruments Protein Crystallization and Crystallography Product Portfolio
  30. 8.5.5 Art Robbins Instruments Recent Developments
  31. 8.6 Molecular Dimensions
  32. 8.6.1 Molecular Dimensions Company Information
  33. 8.6.2 Molecular Dimensions Business Overview
  34. 8.6.3 Molecular Dimensions Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Molecular Dimensions Protein Crystallization and Crystallography Product Portfolio
  36. 8.6.5 Molecular Dimensions Recent Developments
  37. 8.7 Tecan
  38. 8.7.1 Tecan Company Information
  39. 8.7.2 Tecan Business Overview
  40. 8.7.3 Tecan Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tecan Protein Crystallization and Crystallography Product Portfolio
  42. 8.7.5 Tecan Recent Developments
  43. 8.8 FEI
  44. 8.8.1 FEI Company Information
  45. 8.8.2 FEI Business Overview
  46. 8.8.3 FEI Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FEI Protein Crystallization and Crystallography Product Portfolio
  48. 8.8.5 FEI Recent Developments
  49. 8.9 MiTeGen
  50. 8.9.1 MiTeGen Company Information
  51. 8.9.2 MiTeGen Business Overview
  52. 8.9.3 MiTeGen Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MiTeGen Protein Crystallization and Crystallography Product Portfolio
  54. 8.9.5 MiTeGen Recent Developments
  55. 8.10 QIAGEN
  56. 8.10.1 QIAGEN Company Information
  57. 8.10.2 QIAGEN Business Overview
  58. 8.10.3 QIAGEN Protein Crystallization and Crystallography Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QIAGEN Protein Crystallization and Crystallography Product Portfolio
  60. 8.10.5 QIAGEN Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research